{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2014 sorted by posted_date descending", "rows": [["FDA-2014-D-2254-0001", "FDA", "FDA-2014-D-2254", "The Drug Supply Chain Security Act Implementation Product Tracing Requirements Compliance Policy Guidance for Industry Availability", "Notice", "Notice of Availability", "2014-12-31T05:00:00Z", 2014, 12, "2014-12-31T05:00:00Z", null, "2024-11-12T05:33:45Z", "2014-30608", 1, 0, "090000648199bfdc"], ["FDA-2014-N-1936-0002", "FDA", "FDA-2014-N-1936", "Electronic Cigarettes and the Public Health Public Workshop", "Notice", "Meeting", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", null, "2015-03-04T12:21:12Z", "2014-30450", 0, 0, "0900006481999bbf"], ["FDA-2007-D-0369-0310", "FDA", "FDA-2007-D-0369", "Draft and Revised Draft Guidances for Industry Describing Product Specific Bioequivalence Recommendations Availability", "Notice", "Notice of Availability", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", "2015-03-03T04:59:59Z", "2024-11-12T05:29:27Z", "2014-30514", 1, 0, "0900006481999bc7"], ["FDA-2014-N-0797-0002", "FDA", "FDA-2014-N-0797", "Agency Information Collection Activities; Submission for Office of Management and Budget Review Comment Request Guidance Medical \nDevice ISO 13485 2003 Voluntary Audit Report Submission Pilot Program", "Notice", "30 Day Proposed Information Collection", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", "2015-01-30T04:59:59Z", "2014-12-30T17:02:11Z", "2014-30513", 0, 0, "0900006481999c8a"], ["FDA-2014-N-1027-0003", "FDA", "FDA-2014-N-1027", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval Infant Formula Recall Regulations", "Notice", "Notice of Approval", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", null, "2014-12-30T17:09:20Z", "2014-30461", 0, 0, "0900006481999d89"], ["FDA-2014-D-2065-0001", "FDA", "FDA-2014-D-2065", "Radiation Biodosimetry Devices Draft Guidance for Industry and Food and Drug Administration Staff Availability", "Notice", "Notice of Availability", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", "2015-03-31T03:59:59Z", "2024-11-12T05:30:49Z", "2014-30453", 1, 0, "09000064819999f5"], ["FDA-2014-N-0998-0002", "FDA", "FDA-2014-N-0998", "Agency Information Collection Activities Submission for Office of Management and Budget Review Comment Request Regulations for In \nVivo Radiopharmaceuticals Used for Diagnosis and Monitoring", "Notice", "30 Day Proposed Information Collection", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", "2015-01-30T04:59:59Z", "2015-03-08T19:42:01Z", "2014-30452", 0, 0, "0900006481999bc3"], ["FDA-2014-N-0001-0104", "FDA", "FDA-2014-N-0001", "Science Board to the Food and Drug Administration Notice of Meeting", "Notice", "Public Meetings", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", null, "2014-12-30T15:34:56Z", "2014-30516", 0, 0, "0900006481999ad1"], ["FDA-2011-N-0672-0003", "FDA", "FDA-2011-N-0672", "Agency Information Collection Activities Proposed Collection Comment Request Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices", "Notice", "60 Day Proposed Information Collection", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", "2015-03-03T04:59:59Z", "2015-04-08T13:06:22Z", "2014-30511", 0, 0, "0900006481999b05"], ["FDA-2014-N-0001-0105", "FDA", "FDA-2014-N-0001", "Guidance: Advisory Committees; Filing of Closed Meeting Reports", "Notice", "Report Submissions", "2014-12-30T05:00:00Z", 2014, 12, "2014-12-30T05:00:00Z", null, "2014-12-30T16:05:56Z", "2014-30460", 0, 0, "0900006481999b53"], ["FDA-2014-N-2214-0001", "FDA", "FDA-2014-N-2214", "Next Generation Sequencing Diagnostic Tests Public Workshop Request for Comments", "Notice", "Request for Comments", "2014-12-29T05:00:00Z", 2014, 12, "2014-12-29T05:00:00Z", "2015-03-21T03:59:59Z", "2015-03-22T02:01:51Z", "2014-30308", 0, 0, "0900006481995ff6"], ["FDA-2014-N-2104-0001", "FDA", "FDA-2014-N-2104", "Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection of Ebola Zaire Virus; Availability", "Notice", "Notice of Availability", "2014-12-24T05:00:00Z", 2014, 12, "2014-12-24T05:00:00Z", null, "2014-12-24T19:05:36Z", "2014-30108", 0, 0, "09000064819914d1"], ["FDA-2010-N-0155-0207", "FDA", "FDA-2010-N-0155", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Veterinary Feed\nDirective", "Notice", "30 Day Proposed Information Collection", "2014-12-24T05:00:00Z", 2014, 12, "2014-12-24T05:00:00Z", "2015-01-24T04:59:59Z", "2015-01-08T03:01:55Z", "2014-30157", 0, 0, "090000648199147f"], ["FDA-2014-D-1461-0003", "FDA", "FDA-2014-D-1461", "Rare Pediatric Disease Priority Review Vouchers; Extension of Comment\nPeriod", "Notice", "Extension of Comment Period", "2014-12-24T05:00:00Z", 2014, 12, "2014-12-24T05:00:00Z", "2015-02-17T04:59:59Z", "2015-03-25T02:02:24Z", "2014-30154", 0, 0, "09000064819914d2"], ["FDA-2014-N-0001-0103", "FDA", "FDA-2014-N-0001", "General and Plastic Surgery Devices Panel of the Medical Devices Advisory\nCommittee; Notice of Meeting", "Notice", "Public Meetings", "2014-12-24T05:00:00Z", 2014, 12, null, null, "2014-12-24T17:20:01Z", "2014-30149", 0, 0, "0900006481991291"], ["FDA-2007-D-0369-0309", "FDA", "FDA-2007-D-0369", "Bioequivalence Recommendations for Methylphenidate Hydrochloride\nExtended-Release Oral Suspension; Draft Guidance for Industry;\nAvailability", "Notice", "Notice of Availability", "2014-12-24T05:00:00Z", 2014, 12, "2014-12-24T05:00:00Z", "2015-02-24T04:59:59Z", "2015-02-24T03:14:02Z", "2014-30109", 0, 0, "09000064819910d4"], ["FDA-2014-D-1696-0001", "FDA", "FDA-2014-D-1696", "Minimal Manipulation of Human Cells Tissues and Cellular and Tissue Based Products Draft Guidance for Industry and Food and Drug Administration Staff Availability", "Notice", "Notice of Availability", "2014-12-23T05:00:00Z", 2014, 12, "2014-12-23T05:00:00Z", "2015-02-24T04:59:59Z", "2015-02-25T03:05:07Z", "2014-30011", 0, 0, "090000648198eace"], ["FDA-2008-D-0588-0003", "FDA", "FDA-2008-D-0588", "Compliance Policy Guide Sec. 540.700 Labeling of Processed and \nBlended Seafood Products Made Primarily With Fish Protein Availability", "Notice", "Notice of Availability", "2014-12-23T05:00:00Z", 2014, 12, "2014-12-23T05:00:00Z", null, "2024-11-12T05:32:10Z", "2014-30015", 1, 0, "090000648198e78d"], ["FDA-2014-N-1076-0002", "FDA", "FDA-2014-N-1076", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Formal Dispute Resolution--Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice", "Notice", "30 Day Proposed Information Collection", "2014-12-23T05:00:00Z", 2014, 12, "2014-12-23T05:00:00Z", "2015-01-23T04:59:59Z", "2015-03-09T11:23:38Z", "2014-29917", 0, 0, "090000648198e9c6"], ["FDA-2014-N-1104-0003", "FDA", "FDA-2014-N-1104", "Agency Information Collection Activities Announcement of Office of Management and Budget Approval State Petitions for Exemption From \nPreemption", "Notice", "Notice of Approval", "2014-12-23T05:00:00Z", 2014, 12, "2014-12-23T05:00:00Z", null, "2014-12-23T16:22:55Z", "2014-30012", 0, 0, "090000648198eb22"], ["FDA-2009-D-0268-0011", "FDA", "FDA-2009-D-0268", "Labeling of Certain Beers Subject to the Labeling Jurisdiction of the Food and Drug Administration Guidance for Industry Availability", "Notice", "Notice of Availability", "2014-12-23T05:00:00Z", 2014, 12, "2014-12-23T05:00:00Z", null, "2014-12-23T14:58:05Z", "2014-29988", 0, 0, "090000648198e9cb"], ["FDA-2014-N-0001-0101", "FDA", "FDA-2014-N-0001", "Vaccines and Related Biological Products Advisory Committee Notice of Meeting", "Notice", "Meeting", "2014-12-22T05:00:00Z", 2014, 12, "2014-12-22T05:00:00Z", null, "2014-12-22T14:37:50Z", "2014-29860", 0, 0, "090000648198b2c1"], ["FDA-2013-N-1504-0004", "FDA", "FDA-2013-N-1504", "Independent Assessment of the Process for the Review of Device \nSubmissions Final Implementation Plan", "Notice", "Availability of Environmental Assessment", "2014-12-22T05:00:00Z", 2014, 12, "2014-12-22T05:00:00Z", null, "2014-12-22T14:19:33Z", "2014-29800", 0, 0, "090000648198ab1d"], ["FDA-2014-D-1837-0001", "FDA", "FDA-2014-D-1837", "Transfer of a Premarket Notification 510k Clearance Questions and Answers Draft Guidance for Industry and Food and Drug Administration Staff Availability", "Notice", "Notice of Availability", "2014-12-22T05:00:00Z", 2014, 12, "2014-12-22T05:00:00Z", "2015-03-24T03:59:59Z", "2015-03-24T02:04:37Z", "2014-29832", 0, 0, "090000648198b246"], ["FDA-2008-N-0144-0012", "FDA", "FDA-2008-N-0144", "Agency Information Collection Activities; Submission for Office of Management and Budget Review Comment Request Certification to  Accompany Drug Biological Product and Device Applications or Submissions", "Notice", "30 Day Proposed Information Collection", "2014-12-19T05:00:00Z", 2014, 12, "2014-12-19T05:00:00Z", "2015-01-21T04:59:59Z", "2014-12-19T21:02:38Z", "2014-29752", 0, 0, "0900006481985e03"], ["FDA-2008-D-0128-0008", "FDA", "FDA-2008-D-0128", "Serious Drug-Induced Liver Injury The Importance of Getting It Right How To Measure and Interpret Drug-Induced Liver Injury Information and Make Correct Diagnoses Public Conference Request for Comments", "Notice", "Notice of Conference", "2014-12-19T05:00:00Z", 2014, 12, "2014-12-19T05:00:00Z", null, "2016-01-06T18:58:08Z", "2014-29720", 0, 0, "0900006481985fad"], ["FDA-2012-D-1092-0004", "FDA", "FDA-2012-D-1092", "Minimizing Risk for Children's Toy Laser Products Guidance for Industry and Food and Drug Administration Staff Availability", "Notice", "Notice of Availability", "2014-12-19T05:00:00Z", 2014, 12, "2014-12-19T05:00:00Z", null, "2014-12-22T21:42:15Z", "2014-29725", 0, 0, "0900006481985ecb"], ["FDA-2014-N-2137-0001", "FDA", "FDA-2014-N-2137", "Public Meeting on Patient-Focused Drug Development for Breast Cancer Request for Comments", "Notice", "Request for Comments", "2014-12-19T05:00:00Z", 2014, 12, "2014-12-19T05:00:00Z", "2015-06-03T03:59:59Z", "2015-06-03T01:30:57Z", "2014-29721", 0, 0, "0900006481985d1e"], ["FDA-2012-D-0097-0036", "FDA", "FDA-2012-D-0097", "Providing Regulatory Submissions in Electronic Format Standardized Study Data Guidance for Industry Availability", "Notice", "Notice of Availability", "2014-12-18T05:00:00Z", 2014, 12, "2014-12-18T05:00:00Z", null, "2014-12-18T16:26:29Z", "2014-29608", 0, 0, "09000064819823bb"], ["FDA-2014-D-0313-0004", "FDA", "FDA-2014-D-0313", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration \nStaff on Meetings With the Office of Orphan Products Development", "Notice", "30 Day Proposed Information Collection", "2014-12-18T05:00:00Z", 2014, 12, "2014-12-18T05:00:00Z", "2015-01-21T04:59:59Z", "2015-07-09T14:25:12Z", "2014-29612", 0, 0, "0900006481982289"], ["FDA-2011-N-0085-0005", "FDA", "FDA-2011-N-0085", "Agency Information Collection Activities Submission for Office \nof Management and Budget Review Comment Request Guidance for \nIndustry Cooperative Manufacturing Arrangements for Licensed Biologics", "Notice", "30 Day Proposed Information Collection", "2014-12-18T05:00:00Z", 2014, 12, "2014-12-18T05:00:00Z", "2015-01-21T04:59:59Z", "2014-12-18T16:15:06Z", "2014-29611", 0, 0, "0900006481982302"], ["FDA-2014-N-0996-0002", "FDA", "FDA-2014-N-0996", "Agency Information Collection Activities; Submission for Office of Management and Budget Review Comment Request Guidance for \nIndustry Fast Track Drug Development Programs Designation \nDevelopment and Application Review", "Notice", "30 Day Proposed Information Collection", "2014-12-18T05:00:00Z", 2014, 12, "2014-12-18T05:00:00Z", "2015-01-21T04:59:59Z", "2015-03-08T20:14:46Z", "2014-29607", 0, 0, "090000648198240f"], ["FDA-2014-N-2033-0001", "FDA", "FDA-2014-N-2033", "Agency Information Collection Activities; Proposed Collection Comment Request; Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Institutional Foodservice and Retail Food Stores Facility Types", "Notice", "60 Day Proposed Information Collection", "2014-12-17T05:00:00Z", 2014, 12, "2014-12-17T05:00:00Z", "2015-02-18T04:59:59Z", "2014-12-17T14:23:44Z", "2014-29478", 0, 0, "090000648197e869"], ["FDA-2014-N-0809-0002", "FDA", "FDA-2014-N-0809", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Requirements for Submission of Bioequivalence Data", "Notice", "Request for Comments", "2014-12-16T05:00:00Z", 2014, 12, "2014-12-16T05:00:00Z", "2015-01-16T04:59:59Z", "2014-12-16T16:18:37Z", "2014-29425", 0, 0, "090000648197bbaf"], ["FDA-2014-D-1842-0001", "FDA", "FDA-2014-D-1842", "Crabmeat--Fresh and Frozen--Adulteration With Filth, Involving \nthe Presence of Escherichia coli; Compliance Policy Guide; Draft \nGuidance for Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2014-12-16T05:00:00Z", 2014, 12, "2014-12-16T05:00:00Z", "2015-02-18T04:59:59Z", "2014-12-16T17:39:16Z", "2014-29314", 0, 0, "090000648197badf"], ["FDA-2014-N-1697-0002", "FDA", "FDA-2014-N-1697", "Privacy Act of 1974; Report of a New System of Records; Food and \nDrug Administration Commissioning of State and Local Officials; \nCorrection", "Notice", "Correction", "2014-12-16T05:00:00Z", 2014, 12, "2014-12-16T05:00:00Z", "2015-01-23T04:59:59Z", "2014-12-16T15:41:51Z", "2014-29424", 0, 0, "090000648197ba94"], ["FDA-2014-N-1409-0002", "FDA", "FDA-2014-N-1409", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Records and Reports Concerning Experiences With Approved New Animal Drugs: Adverse Event Reports", "Notice", "Request for Comments", "2014-12-16T05:00:00Z", 2014, 12, "2014-12-16T05:00:00Z", "2015-01-16T04:59:59Z", "2014-12-16T16:31:29Z", "2014-29426", 0, 0, "090000648197c119"], ["FDA-2014-N-0987-0006", "FDA", "FDA-2014-N-0987", "Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications", "Notice", "60 Day Proposed Information Collection", "2014-12-12T05:00:00Z", 2014, 12, "2014-12-12T05:00:00Z", "2014-10-01T03:59:59Z", "2014-12-13T03:07:08Z", "2014-18195", 0, 0, "0900006481973c49"], ["FDA-2014-N-2076-0001", "FDA", "FDA-2014-N-2076", "Agency Information Collection Activities; Proposed Collection;  Comment Request; Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Restaurant Facility Types", "Notice", "60 Day Proposed Information Collection", "2014-12-11T05:00:00Z", 2014, 12, "2014-12-11T05:00:00Z", "2015-02-10T04:59:59Z", "2014-12-15T03:01:30Z", "2014-29065", 0, 0, "090000648196da00"], ["FDA-2014-N-1960-0001", "FDA", "FDA-2014-N-1960", "Agency Information Collection Activities; Proposed Collection; Comment Request; MedWatch: The Food and Drug Administration Medical Products Reporting Program", "Notice", "60 Day Proposed Information Collection", "2014-12-11T05:00:00Z", 2014, 12, "2014-12-11T05:00:00Z", "2015-02-10T04:59:59Z", "2015-02-10T03:01:31Z", "2014-29064", 0, 0, "090000648196db4e"], ["FDA-2008-P-0320-0004", "FDA", "FDA-2008-P-0320", "Determination That PFIZERPEN (Penicillin G Potassium) Injection, 1 Million Units/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2014-12-11T05:00:00Z", 2014, 12, "2014-12-11T05:00:00Z", null, "2014-12-11T21:23:52Z", "2014-29034", 0, 0, "090000648196daf6"], ["FDA-2007-D-0369-0308", "FDA", "FDA-2007-D-0369", "Bioequivalence Recommendations for Budesonide Extended-Release \nTablets; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-12-11T05:00:00Z", 2014, 12, "2014-12-11T05:00:00Z", "2015-02-10T04:59:59Z", "2015-02-10T03:01:55Z", "2014-29035", 0, 0, "090000648196d9d1"], ["FDA-2010-D-0073-0001", "FDA", "FDA-2010-D-0073", "Agency Information Collection Activities; Proposed Collection; \nComment Request; Guidance on Consultation Procedures: Foods Derived \nFrom New Plant Varieties", "Notice", "60 Day Proposed Information Collection", "2014-12-11T05:00:00Z", 2014, 12, "2014-12-11T05:00:00Z", "2015-02-10T04:59:59Z", "2014-12-12T03:11:47Z", "2014-29046", 0, 0, "090000648196daaf"], ["FDA-2014-N-2029-0001", "FDA", "FDA-2014-N-2029", "Agency Information Collection Activities; Proposed Collection; \nComment Request; Administrative Practices and Procedures; Formal \nEvidentiary Public Hearing", "Notice", "60 Day Proposed Information Collection", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", "2015-02-10T04:59:59Z", "2014-12-12T00:08:03Z", "2014-28825", 0, 0, "090000648196aa0c"], ["FDA-2014-N-1998-0001", "FDA", "FDA-2014-N-1998", "Patient-Focused Drug Development Public Meeting on Chagas Disease", "Notice", "Public Meetings", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", "2015-06-30T03:59:59Z", "2015-07-10T01:30:44Z", "2014-28828", 0, 0, "090000648196ab25"], ["FDA-2014-N-2032-0001", "FDA", "FDA-2014-N-2032", "Request for Nominations for Voting Members on the Food Advisory \nCommittee", "Notice", "Request for Nominations", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", null, "2014-12-10T14:36:12Z", "2014-28889", 0, 0, "090000648196a9b4"], ["FDA-2011-D-0588-0004", "FDA", "FDA-2011-D-0588", "International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Guidance for Industry on Pharmacovigilance of Veterinary Medicinal Products: Electronic\nStandards for Transfer of Data; Availability", "Notice", "Notice of Availability", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", null, "2024-11-12T05:32:29Z", "2014-28830", 1, 0, "090000648196aa72"], ["FDA-2014-N-0001-0099", "FDA", "FDA-2014-N-0001", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Public Meetings", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", null, "2014-12-10T14:23:49Z", "2014-28847", 0, 0, "090000648196a971"], ["FDA-2014-N-0001-0100", "FDA", "FDA-2014-N-0001", "Orthopaedic and Rehabilitation Devices Panel of the Medical \nDevices Advisory Committee; Notice of Postponement of Meeting", "Notice", "Meeting Postponement", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", null, "2014-12-10T14:32:39Z", "2014-28881", 0, 0, "090000648196a973"], ["FDA-2013-D-1067-0004", "FDA", "FDA-2013-D-1067", "Patient Counseling Information Section of Labeling for Human \nPrescription Drug and Biological Products--Content and Format; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-12-10T05:00:00Z", 2014, 12, "2014-12-10T05:00:00Z", null, "2024-11-12T05:32:29Z", "2014-28888", 1, 0, "090000648196aa70"], ["FDA-2014-N-0987-0005", "FDA", "FDA-2014-N-0987", "Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications; Correction", "Notice", "Correction", "2014-12-09T05:00:00Z", 2014, 12, "2014-12-09T05:00:00Z", null, "2014-12-12T23:31:53Z", "2014-28714", 0, 0, "090000648196810f"], ["FDA-2014-D-2083-0001", "FDA", "FDA-2014-D-2083", "Draft Guidance for Industry on Drug Supply Chain Security Act \nImplementation: Annual Reporting by Prescription Drug Wholesale \nDistributors and Third-Party Logistics Providers; Availability", "Notice", "Notice of Availability", "2014-12-09T05:00:00Z", 2014, 12, "2014-12-09T05:00:00Z", "2015-02-10T04:59:59Z", "2020-04-23T18:06:28Z", "2014-28711", 0, 0, "0900006481968115"], ["FDA-2014-D-1492-0003", "FDA", "FDA-2014-D-1492", "Two-Phased Chemistry, Manufacturing, and Controls Technical \nSections; Draft Guidance for Industry; Extension of Comment Period", "Notice", "Extension of Comment Period", "2014-12-09T05:00:00Z", 2014, 12, "2014-12-09T05:00:00Z", "2015-02-18T04:59:59Z", "2015-03-19T02:12:12Z", "2014-28713", 0, 0, "0900006481967c1e"], ["FDA-2013-D-1275-0001", "FDA", "FDA-2013-D-1275", "General Clinical Pharmacology Considerations for Pediatric \nStudies for Drugs and Biological Products; Draft Guidance for Industry; \nAvailability", "Notice", "Notice of Availability", "2014-12-09T05:00:00Z", 2014, 12, "2014-12-09T05:00:00Z", "2015-02-10T04:59:59Z", "2015-02-25T03:05:16Z", "2014-28716", 0, 0, "0900006481967c22"], ["FDA-2014-D-1814-0001", "FDA", "FDA-2014-D-1814", "Bacterial Detection Testing by Blood Collection Establishments \nand Transfusion Services To Enhance the Safety and Availability of \nPlatelets for Transfusion; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-12-09T05:00:00Z", 2014, 12, "2014-12-09T05:00:00Z", "2015-02-10T04:59:59Z", "2015-01-04T02:57:01Z", "2014-28809", 0, 0, "09000064819681fe"], ["FDA-2014-N-0001-0098", "FDA", "FDA-2014-N-0001", "Endocrinologic and Metabolic Drugs Advisory Committee; Notice of \nMeeting", "Notice", "Meeting", "2014-12-09T05:00:00Z", 2014, 12, "2014-12-09T05:00:00Z", null, "2014-12-09T14:48:56Z", "2014-28702", 0, 0, "0900006481967c76"], ["FDA-2014-N-2031-0001", "FDA", "FDA-2014-N-2031", "Request for Nominations on the Food Advisory Committee", "Notice", "Request for Nominations", "2014-12-08T05:00:00Z", 2014, 12, "2014-12-08T05:00:00Z", "2015-01-08T04:59:59Z", "2014-12-08T16:28:40Z", "2014-28652", 0, 0, "0900006481964124"], ["FDA-2014-N-0987-0004", "FDA", "FDA-2014-N-0987", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications", "Notice", "30 Day Proposed Information Collection", "2014-12-08T05:00:00Z", 2014, 12, "2014-12-08T05:00:00Z", "2014-12-09T04:59:59Z", "2014-12-12T23:38:02Z", "2014-28635", 0, 0, "0900006481963f5e"], ["FDA-2014-N-1697-0001", "FDA", "FDA-2014-N-1697", "Privacy Act of 1974; Report of a New System of Records; Food and \nDrug Administration Commissioning of State and Local Officials", "Notice", "Privacy Act System of Records", "2014-12-08T05:00:00Z", 2014, 12, "2014-12-08T05:00:00Z", "2015-01-23T04:59:59Z", "2014-12-08T16:20:47Z", "2014-28634", 0, 0, "090000648196402c"], ["FDA-2014-D-1891-0001", "FDA", "FDA-2014-D-1891", "How To Obtain a Letter From the Food and Drug Administration Stating That Bioequivalence Study Protocols Contain Safety Protections\nComparable to Applicable Risk Evaluation and Mitigation Strategies\nfor Reference Listed Drugs; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-12-05T05:00:00Z", 2014, 12, "2014-12-05T05:00:00Z", "2015-02-04T04:59:59Z", "2020-04-23T19:23:52Z", "2014-28540", 0, 0, "090000648195e613"], ["FDA-2014-N-1795-0001", "FDA", "FDA-2014-N-1795", "Mallinckrodt Inc. et al.; Withdrawal of Approval of 23 New Drug Applications and 68 Abbreviated New Drug Applications", "Notice", "Withdrawal", "2014-12-05T05:00:00Z", 2014, 12, "2014-12-05T05:00:00Z", null, "2014-12-05T15:11:49Z", "2014-28541", 0, 0, "090000648195e55c"], ["FDA-2014-D-1551-0001", "FDA", "FDA-2014-D-1551", "Pregnancy, Lactation, and Reproductive Potential: Labeling for\nHuman Prescription Drug and Biological Products\u2014Content and\nFormat; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-12-04T05:00:00Z", 2014, 12, "2014-12-04T05:00:00Z", "2015-02-03T04:59:59Z", "2015-02-03T03:15:00Z", "2014-28242", 0, 0, "090000648195a5df"], ["FDA-2013-D-0295-0010", "FDA", "FDA-2013-D-0295", "Guidance for Industry on Scale-Up Post-Approval Changes:\nManufacturing Equipment Addendum; Availability", "Notice", "Notice of Availability", "2014-12-02T05:00:00Z", 2014, 12, "2014-12-02T05:00:00Z", null, "2014-12-02T16:29:51Z", "2014-28256", 0, 0, "0900006481953f5c"], ["FDA-2010-D-0194-0024", "FDA", "FDA-2010-D-0194", "Infusion Pumps Total Product Life Cycle; Guidance for Industry and Food\nand Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2014-12-02T05:00:00Z", 2014, 12, "2014-12-02T05:00:00Z", null, "2014-12-02T17:21:26Z", "2014-28267", 0, 0, "0900006481953fe6"], ["FDA-2013-D-0168-0009", "FDA", "FDA-2013-D-0168", "Recommendations for Labeling Medical Products To Inform Users That\nthe Product or Product Container Is Not Made With Natural Rubber Latex;\nGuidance for Industry and Food and Drug Administration Staff; Availability.", "Notice", "Notice of Availability", "2014-12-02T05:00:00Z", 2014, 12, "2014-12-02T05:00:00Z", null, "2014-12-02T16:23:58Z", "2014-28265", 0, 0, "0900006481953f62"], ["FDA-2014-N-1936-0001", "FDA", "FDA-2014-N-1936", "Establishment of a Public Docket; Electronic Cigarettes and the Public Health Workshop", "Notice", "Request for Comments", "2014-12-02T05:00:00Z", 2014, 12, "2014-12-02T05:00:00Z", "2015-04-16T03:59:59Z", "2015-07-15T12:41:06Z", "2014-28261", 0, 0, "0900006481953f90"], ["FDA-2014-N-0639-0002", "FDA", "FDA-2014-N-0639", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Notification of the\nIntent To Use an Accredited Person Under the Accredited Persons\nInspection Program", "Notice", "30 Day Proposed Information Collection", "2014-12-01T05:00:00Z", 2014, 12, "2014-12-01T05:00:00Z", "2014-12-02T04:59:59Z", "2014-12-13T20:55:06Z", "2014-28184", 0, 0, "0900006481950b67"], ["FDA-2014-N-1952-0001", "FDA", "FDA-2014-N-1952", "Seventh Annual Sentinel Initiative; Public Workshop; Amendment of\nNotice", "Notice", "Meeting", "2014-12-01T05:00:00Z", 2014, 12, "2014-12-01T05:00:00Z", "2015-03-11T03:59:59Z", "2014-12-01T15:00:48Z", "2014-28196", 0, 0, "0900006481950b62"], ["FDA-2014-N-1030-0002", "FDA", "FDA-2014-N-1030", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Food Allergen\nLabeling and Reporting", "Notice", "30 Day Proposed Information Collection", "2014-12-01T05:00:00Z", 2014, 12, "2014-12-01T05:00:00Z", "2014-12-02T04:59:59Z", "2014-12-13T20:56:46Z", "2014-28185", 0, 0, "0900006481950a43"], ["FDA-2011-N-0619-0004", "FDA", "FDA-2011-N-0619", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Medical Devices;\nHumanitarian Use Devices", "Notice", "30 Day Proposed Information Collection", "2014-12-01T05:00:00Z", 2014, 12, "2014-12-01T05:00:00Z", "2014-12-02T04:59:59Z", "2014-12-13T20:55:54Z", "2014-28183", 0, 0, "0900006481950a3d"], ["FDA-2013-N-1152-0003", "FDA", "FDA-2013-N-1152", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Petition To\nRequest an Exemption From 100 Percent Identity Testing of Dietary\nIngredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements", "Notice", "30 Day Proposed Information Collection", "2014-11-28T05:00:00Z", 2014, 11, "2014-11-28T05:00:00Z", "2014-11-29T04:59:59Z", "2014-12-13T20:54:28Z", "2014-28087", 0, 0, "090000648194b565"], ["FDA-2014-N-0987-0003", "FDA", "FDA-2014-N-0987", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications", "Notice", "30 Day Proposed Information Collection", "2014-11-28T05:00:00Z", 2014, 11, "2014-11-28T05:00:00Z", "2014-11-29T04:59:59Z", "2014-12-12T23:37:08Z", "2014-28106", 0, 0, "090000648194b257"], ["FDA-2014-N-1904-0001", "FDA", "FDA-2014-N-1904", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Comparing Food Safety Knowledge, Attitude, and\nBehavior Among English-Dominant Hispanics, Spanish-Dominant Hispanics, and Other Consumers", "Notice", "60 Day Proposed Information Collection", "2014-11-28T05:00:00Z", 2014, 11, "2014-11-28T05:00:00Z", "2015-01-28T04:59:59Z", "2014-11-28T14:28:03Z", "2014-28088", 0, 0, "090000648194b1da"], ["FDA-2014-D-1862-0001", "FDA", "FDA-2014-D-1862", "Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-11-28T05:00:00Z", 2014, 11, "2014-11-28T05:00:00Z", "2015-01-28T04:59:59Z", "2015-01-28T03:22:04Z", "2014-28086", 0, 0, "090000648194b65d"], ["FDA-2014-D-1981-0001", "FDA", "FDA-2014-D-1981", "The Drug Supply Chain Security Act Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs: How To Exchange Product Tracing Information; Availability", "Notice", "Notice of Availability", "2014-11-28T05:00:00Z", 2014, 11, "2014-11-28T05:00:00Z", null, "2022-07-06T14:58:35Z", "2014-28085", 0, 0, "090000648194a808"], ["FDA-2014-D-1804-0001", "FDA", "FDA-2014-D-1804", "Immediately in Effect Guidance Document: Product Labeling for \nLaparoscopic Power Morcellators; Guidance for Industry and Food and \nDrug Administration Staff; Availability", "Notice", "Notice of Availability", "2014-11-25T05:00:00Z", 2014, 11, "2014-11-25T05:00:00Z", "2015-01-27T04:59:59Z", "2015-01-25T02:57:39Z", "2014-27857", 0, 0, "0900006481944332"], ["FDA-2011-D-0360-0003", "FDA", "FDA-2011-D-0360", "Framework for Regulatory Oversight of Laboratory Developed Tests; Public\nWorkshop; Request for Comments", "Notice", "Request for Comments", "2014-11-24T05:00:00Z", 2014, 11, "2014-11-24T05:00:00Z", "2015-02-03T04:59:59Z", "2015-02-21T03:01:26Z", "2014-27713", 0, 0, "090000648194152d"], ["FDA-2013-N-1429-0011", "FDA", "FDA-2013-N-1429", "Registration of Human Drug Compounding Outsourcing Facilities\nUnder Section 503B of the FD&C Act; Final Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-11-24T05:00:00Z", 2014, 11, "2014-11-24T05:00:00Z", null, "2020-04-23T20:13:48Z", "2014-27693", 0, 0, "090000648194152e"], ["FDA-2013-N-1428-0010", "FDA", "FDA-2013-N-1428", "Electronic Product Reporting for Human Drug Compounding Outsourcing Facilities; Draft Guidance", "Notice", "Notice of Availability", "2014-11-24T05:00:00Z", 2014, 11, "2014-11-24T05:00:00Z", "2015-01-24T04:59:59Z", "2019-07-17T12:23:03Z", "2014-27691", 0, 0, "09000064819413b6"], ["FDA-2014-N-1818-0001", "FDA", "FDA-2014-N-1818", "New Clinical Trials Demographic Data; Availability for Comment", "Notice", "Notice of Availability", "2014-11-24T05:00:00Z", 2014, 11, "2014-11-24T05:00:00Z", "2015-01-24T04:59:59Z", "2015-01-25T02:56:52Z", "2014-27732", 0, 0, "0900006481941403"], ["FDA-2014-D-0329-0004", "FDA", "FDA-2014-D-0329", "Fees for Human Drug Compounding Outsourcing Facilities Under the FD&C Act; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-11-24T05:00:00Z", 2014, 11, "2014-11-24T05:00:00Z", null, "2017-04-05T13:49:47Z", "2014-27692", 0, 0, "0900006481941448"], ["FDA-2011-D-0357-0003", "FDA", "FDA-2011-D-0357", "Framework for Regulatory Oversight of Laboratory Developed Tests; Public\nWorkshop; Request for Comments", "Notice", "Request for Comments", "2014-11-24T05:00:00Z", 2014, 11, "2014-11-24T05:00:00Z", "2015-02-03T04:59:59Z", "2015-02-03T03:13:23Z", "2014-27713", 0, 0, "09000064819425ac"], ["FDA-2013-N-0502-0050", "FDA", "FDA-2013-N-0502", "Report on the Standardization of Risk Evaluation and Mitigation Strategies;\nCorrection", "Notice", "Correction", "2014-11-21T05:00:00Z", 2014, 11, "2014-11-21T05:00:00Z", null, "2014-11-21T19:01:09Z", "2014-27522", 0, 0, "090000648193d6aa"], ["FDA-2014-N-0001-0097", "FDA", "FDA-2014-N-0001", "Developing and Using Precision Therapies in the \u2018\u2018Omics\u2019\u2019 Era:\nGenerating and Interpreting Evidence for Rare Subsets; Public Workshop", "Notice", "Meeting", "2014-11-21T05:00:00Z", 2014, 11, "2014-11-21T05:00:00Z", null, "2014-11-21T18:34:55Z", "2014-27523", 0, 0, "090000648193d51a"], ["FDA-2014-N-0001-0096", "FDA", "FDA-2014-N-0001", "Anti-Infective Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2014-11-21T05:00:00Z", 2014, 11, "2014-11-21T05:00:00Z", null, "2014-11-21T17:41:22Z", "2014-27573", 0, 0, "090000648193d6f0"], ["FDA-1999-D-3528-0006", "FDA", "FDA-1999-D-3528", "Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further\nManufacture; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-11-21T05:00:00Z", 2014, 11, "2014-11-21T05:00:00Z", null, "2014-11-21T18:56:20Z", "2014-27521", 0, 0, "090000648193d6f2"], ["FDA-2011-N-0535-0003", "FDA", "FDA-2011-N-0535", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body", "Notice", "60 Day Proposed Information Collection", "2014-11-21T05:00:00Z", 2014, 11, "2014-11-21T05:00:00Z", "2015-01-21T04:59:59Z", "2014-11-21T18:49:39Z", "2014-27517", 0, 0, "090000648193d5b3"], ["FDA-2011-N-0510-0003", "FDA", "FDA-2011-N-0510", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Substances Prohibited From Use in Animal Food or\nFeed", "Notice", "60 Day Proposed Information Collection", "2014-11-21T05:00:00Z", 2014, 11, "2014-11-21T05:00:00Z", "2015-01-21T04:59:59Z", "2014-11-25T03:01:11Z", "2014-27518", 0, 0, "090000648193d51f"], ["FDA-2014-N-0373-0002", "FDA", "FDA-2014-N-0373", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Risk and Benefit Perception Scale Development", "Notice", "30 Day Proposed Information Collection", "2014-11-20T05:00:00Z", 2014, 11, "2014-11-20T05:00:00Z", "2014-11-21T04:59:59Z", "2014-12-13T20:54:10Z", "2014-27431", 0, 0, "0900006481939878"], ["FDA-2012-D-1120-0011", "FDA", "FDA-2012-D-1120", "Vaginal Microbicides: Development for the Prevention of Human\nImmunodeficiency Virus Infection; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2014-11-19T05:00:00Z", 2014, 11, "2014-11-19T05:00:00Z", null, "2014-11-19T17:02:36Z", "2014-27287", 0, 0, "0900006481937e09"], ["FDA-2014-N-1855-0001", "FDA", "FDA-2014-N-1855", "Agency Information Collection Activities; Proposed Collection;\nComment Request: Experimental Studies on Consumer Perceptions of\nModified Risk Tobacco Products", "Notice", "60 Day Proposed Information Collection", "2014-11-19T05:00:00Z", 2014, 11, "2014-11-19T05:00:00Z", "2015-01-21T04:59:59Z", "2015-01-25T02:53:35Z", "2014-27283", 0, 0, "0900006481937d8e"], ["FDA-2014-N-1741-0001", "FDA", "FDA-2014-N-1741", "Proposed Criteria for \"First Generic\" Submissions for Purposes of Abbreviated New Drug Application Review Prioritization Under the Generic Drug User Fee Amendments", "Notice", "Request for Comments", "2014-11-19T05:00:00Z", 2014, 11, "2014-11-19T05:00:00Z", "2014-12-20T04:59:59Z", "2014-12-20T03:00:43Z", "2014-27385", 0, 0, "0900006481937e0a"], ["FDA-2014-N-1840-0001", "FDA", "FDA-2014-N-1840", "Electronic Study Data Submission;nData Standards; Validation Rules for\nStudy Data Tabulation ModelnFormatted Studies; Availability", "Notice", "Availability of Document", "2014-11-19T05:00:00Z", 2014, 11, "2014-11-19T05:00:00Z", null, "2014-11-19T15:25:19Z", "2014-27384", 0, 0, "0900006481937e7c"], ["FDA-2014-D-1461-0001", "FDA", "FDA-2014-D-1461", "Rare Pediatric Disease Priority Review Vouchers, Draft Guidance for Industry;\nAvailability", "Notice", "Notice of Availability", "2014-11-17T05:00:00Z", 2014, 11, "2014-11-17T05:00:00Z", "2014-12-25T04:59:59Z", "2014-12-24T19:51:24Z", "2014-27022", 0, 0, "0900006481932cf7"], ["FDA-2013-N-1285-0002", "FDA", "FDA-2013-N-1285", "Smith Miller and Patch, Inc. et al.; Withdrawal of Approval of 14 New\nDrug Applications", "Notice", "Withdrawal", "2014-11-17T05:00:00Z", 2014, 11, "2014-11-17T05:00:00Z", null, "2014-11-17T16:05:27Z", "2014-27039", 0, 0, "090000648193331f"], ["FDA-2010-N-0161-0003", "FDA", "FDA-2010-N-0161", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Export of Food and Drug Administration Regulated\nProducts: Export Certificates", "Notice", "60 Day Proposed Information Collection", "2014-11-14T05:00:00Z", 2014, 11, "2014-11-14T05:00:00Z", "2015-01-14T04:59:59Z", "2015-01-26T23:08:14Z", "2014-26999", 0, 0, "090000648192e746"], ["FDA-2013-N-0878-0004", "FDA", "FDA-2013-N-0878", "Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification for a New Dietary Ingredient", "Notice", "60 Day Proposed Information Collection", "2014-11-14T05:00:00Z", 2014, 11, "2014-11-14T05:00:00Z", "2015-01-14T04:59:59Z", "2015-02-11T23:19:04Z", "2014-26998", 0, 0, "090000648192e5a4"], ["FDA-2011-N-0279-0004", "FDA", "FDA-2011-N-0279", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Prescription Drug Marketing Act of 1987; Administrative Procedures, Policies, and Requirements", "Notice", "60 Day Proposed Information Collection", "2014-11-14T05:00:00Z", 2014, 11, "2014-11-14T05:00:00Z", "2015-01-14T04:59:59Z", "2014-11-17T15:55:51Z", "2014-26917", 0, 0, "090000648192e78c"], ["FDA-2014-N-1819-0001", "FDA", "FDA-2014-N-1819", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements", "Notice", "60 Day Proposed Information Collection", "2014-11-14T05:00:00Z", 2014, 11, "2014-11-14T05:00:00Z", "2015-01-14T04:59:59Z", "2015-02-07T03:01:28Z", "2014-26918", 0, 0, "090000648192e604"], ["FDA-1981-D-0242-0001", "FDA", "FDA-1981-D-0242", "Notice of Availability from FDA", "Notice", "Notice of Availability", "2014-11-14T05:00:00Z", 2014, 11, "2014-11-14T05:00:00Z", null, "2014-11-14T21:39:29Z", null, 0, 0, "09000064805b0ae9"]], "truncated": false, "filtered_table_rows_count": 932, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2014"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014", "results": [{"value": "FDA", "label": "FDA", "count": 932, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2014", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014", "results": [{"value": "Notice", "label": "Notice", "count": 932, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2014", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014", "results": [{"value": 2014, "label": 2014, "count": 932, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_facet_date=last_modified"}], "next": "2014-11-14T05~3A00~3A00Z,FDA-1981-D-0242-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2014&_next=2014-11-14T05~3A00~3A00Z%2CFDA-1981-D-0242-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 3464.5622968673706, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}